AOD 9604 5 mg

Peptide Hubs AOD 9604: The Ultimate Research Peptide for Fat Metabolism

Welcome to the forefront of metabolic research. Peptide Hubs is proud to offer premium, USA-stocked AOD 9604 5 mg vials, specifically designed for researchers and laboratory studies. This synthetic peptide fragment represents a significant advancement in the study of fat metabolism and weight management, providing a targeted approach without the traditional side effects associated with growth hormone.

Our AOD 9604 is supplied as a pure, lyophilized powder in a sterile 2 mL vial, ensuring stability and ease of reconstitution for your experimental protocols. Each batch is rigorously lab-tested for purity and authenticity, guaranteeing you receive a reliable and consistent research compound every time you buy AOD 9604 USA from Peptide Hubs.

What is AOD 9604?

AOD 9604 (Anti-Obesity Drug 9604) is a modified fragment of the Growth Hormone (GH) molecule, encompassing the amino acid sequence 177-191. Developed by researchers at Metabolic Pharmaceuticals, this peptide was designed to replicate the lipolytic (fat-burning) properties of GH while deliberately eliminating its negative effects on blood sugar and growth promotion. A study published in the Journal of Endocrinology demonstrated that this fragment potently stimulates lipolysis and inhibits lipogenesis (fat storage) in animal models, making it a compound of high interest in metabolic research.

Effects of AOD 9604

For research purposes, the primary observed effects of AOD 9604 revolve around its potent influence on adipose tissue. Its mechanisms are of particular interest to the bodybuilding and fitness research communities for the following reasons:

• Enhanced Fat Breakdown (Lipolysis): AOD 9604 mimics the way natural growth hormone signals fat cells to break down stored triglycerides into free fatty acids, which can then be used for energy.
• Inhibition of Fat Storage (Lipogenesis): Crucially, it also works to block the creation and storage of new fat cells, creating a powerful dual-action effect that promotes a significant reduction in stubborn fat deposits.
• Metabolic Rate Support: Research suggests it may help support a heightened metabolic rate, aiding in the more efficient utilization of calories.
• Cartilage and Joint Repair: Emerging evidence indicates that AOD 9604 may stimulate cartilage synthesis and promote the repair of joint tissues, which is highly relevant for studies on recovery from intense physical stress.
• No Impact on Blood Sugar: Unlike full-length growth hormone, the AOD 9604 fragment does not interfere with insulin sensitivity or blood glucose levels, a key advantage for metabolic studies.

Dosage and Administration

Important: The following information is based on common research protocols and is provided for educational purposes only. It is essential to consult scientific literature to determine the appropriate dosage for your specific research model.

AOD 9604 is typically administered once or twice per day. Common research dosages range from 300 mcg to 1 mg (1000 mcg) per day. A standard and widely used protocol in research settings involves a daily dose of 500 mcg.

Reconstitution: The lyophilized powder must be reconstituted with Bacteriostatic Water (Bac Water). The amount of water used will determine the concentration. For example, reconstituting a 5 mg vial with 2 mL of Bac Water will yield a concentration of 2500 mcg per mL. This means a 0.2 mL injection would deliver a 500 mcg dose.

Proper aseptic technique is paramount during reconstitution and handling to maintain sterility. For your research needs, Peptide Hubs offers pharmaceutical-grade Bac Water to ensure optimal results.

Cycle and Research Stacking

Research cycles for AOD 9604 typically last between 8 to 12 weeks to observe significant changes in fat metabolism. Due to its specific mechanism of action, it is an excellent candidate for stacking with other research peptides to achieve synergistic effects.

Here are some research stacks involving Peptide Hubs AOD 9604:

• For Enhanced Fat Loss: Stack AOD 9604 with Tesamorelin/Ipamorelin to powerfully stimulate natural GH pulse and maximize lipolysis.
• For Injury Recovery and Fat Loss: Combine with BPC 157 5 mg to study the combined effects on joint repair and metabolic enhancement.
• For Muscle Preservation During Cutting: Add IGF-1 LR3 1 mg to a protocol to investigate its role in promoting muscle growth while AOD 9604 targets fat loss.
• For Overall Metabolic and Anti-Aging Research: Consider stacking with CJC-1295/Ipamorelin for a comprehensive growth hormone secretagogue effect, or with NAD+ 100 mg to support cellular energy and metabolism.

Possible Side Effects

In research models, AOD 9604 is generally well-tolerated due to its targeted design. The reported side effects are rare and typically mild. However, researchers should monitor for the following:

• Transient Headache: Some reports indicate a temporary headache as the body adapts, usually subsiding quickly.
• Localized Discomfort: As with any injection, there is a potential for minor redness, swelling, or itching at the administration site.
• Increased Appetite: A small subset of data suggests a temporary increase in hunger, though this is not a consistent finding.

It is critical to note that AOD 9604 does not exhibit the classic side effects of growth hormone, such as carpal tunnel syndrome, joint pain, or insulin resistance.

Why Choose Peptide Hubs AOD 9604?

When you decide to buy AOD 9604 USA, choosing Peptide Hubs ensures you are partnering with a trusted leader in research compounds. We guarantee the highest standards of purity and product integrity. Our fast, discreet shipping within the United States means your research projects can proceed without delay. Trust Peptide Hubs for all your research peptide needs, from AOD 9604 to a comprehensive range of supporting compounds.

AOD 9604 Profile

Name: AOD 9604
Drug Class: Synthetic Peptide Hormone Fragment
Other common names and terms: Anti-Obesity Drug 9604, GH 177-191
Active Life: Approximately 4-6 hours
Detection Time: Not well-established; estimated 1-2 days
Chemical Structure: Tyr-hGH-(177-191)
Common Doses: 300 mcg - 1000 mcg per day
Blood pressure: No significant effect reported
Acne: No significant effect reported
Water retention: No significant effect reported
Aromatisation: Does not aromatize
Liver toxicity: No liver toxicity reported
Decrease HPTA function: No significant suppression of the HPTA axis